Editas CEO resigns, raising questions about a series of executive departures at nascent CRISPR company
One investor with no position in Editas said Bosley struggled to connect with health care investment funds; the company’s owners are largely mutual funds.
Name: Katrine Bosley
Continent: North America
Country: USA
Company: Editas Medicine
Position: CEO & President
Reason: Resigned
Announcement Date: January 21, 2019, 11:00pm
Resignation Date: January 21, 2019, 11:00pm
Source 1: https://www.statnews.com/2019/01/22/katrine-bosley-editas/